PL2343038T3 - Kompozycje dermatologiczne zawierające połączenie peroksydowanych lipidów i cynku oraz ich zastosowania, zwłaszcza w leczeniu opryszczki - Google Patents

Kompozycje dermatologiczne zawierające połączenie peroksydowanych lipidów i cynku oraz ich zastosowania, zwłaszcza w leczeniu opryszczki

Info

Publication number: PL2343038T3
Authority: PL; Poland
Prior art keywords: herpes; zinc; treatment; combination; dermatological compositions
Prior art date: 2009-12-24

Application number

PL10195981T

Other languages

English (en)

Inventor

STéPHANE DESJONQUERES

Original Assignee

Laboratoires Carilene

Desjonqueres Stephane

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-12-24

Filing date

2010-12-20

Publication date

2015-04-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42227561&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2343038(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-12-20 Application filed by Laboratoires Carilene, Desjonqueres Stephane filed Critical Laboratoires Carilene

2015-04-30 Publication of PL2343038T3 publication Critical patent/PL2343038T3/pl

Links

XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 title 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 title 1
150000002632 lipids Chemical class 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000011701 zinc Substances 0.000 title 1
229910052725 zinc Inorganic materials 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Emergency Medicine (AREA)
Oil, Petroleum & Natural Gas (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)

PL10195981T 2009-12-24 2010-12-20 Kompozycje dermatologiczne zawierające połączenie peroksydowanych lipidów i cynku oraz ich zastosowania, zwłaszcza w leczeniu opryszczki PL2343038T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0959604A FR2954701B1 (fr)	2009-12-24	2009-12-24	Compositions dermatologiques contenant une association de lipides peroxydes et de zinc et leurs utilisations notamment dans le traitement de l'herpes
EP10195981.5A EP2343038B1 (fr)	2009-12-24	2010-12-20	Compositions dermatologiques contenant une association de lipides peroxydés et de zinc et leurs utilisations notamment dans le traitement de l'herpès

Publications (1)

Publication Number	Publication Date
PL2343038T3 true PL2343038T3 (pl)	2015-04-30

Family

ID=42227561

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL10195981T PL2343038T3 (pl)	2009-12-24	2010-12-20	Kompozycje dermatologiczne zawierające połączenie peroksydowanych lipidów i cynku oraz ich zastosowania, zwłaszcza w leczeniu opryszczki

Country Status (13)

Country	Link
US (1)	US9144612B2 (pl)
EP (1)	EP2343038B1 (pl)
AR (1)	AR080633A1 (pl)
BR (1)	BRPI1010325B1 (pl)
CY (1)	CY1115914T1 (pl)
DK (1)	DK2343038T3 (pl)
ES (1)	ES2531407T3 (pl)
FR (1)	FR2954701B1 (pl)
HR (1)	HRP20150027T1 (pl)
PL (1)	PL2343038T3 (pl)
PT (1)	PT2343038E (pl)
RS (1)	RS53787B1 (pl)
SI (1)	SI2343038T1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012136218A1 (en) *	2011-04-04	2012-10-11	Coloplast A/S	An adhesive patch
JP2018507895A (ja) *	2015-03-18	2018-03-22	バイオヌークススイスエスエー	ヘルペスを処置するための方法において使用するためのジヒドロケルセチンを含む組成物
JP6694431B2 (ja) *	2015-06-12	2020-05-13	Ｊｆｅミネラル株式会社	皮膚創傷または皮膚荒れ治療剤
FR3053252B1 (fr) *	2016-06-29	2020-04-24	Laboratoires Carilene	Produit, ou agent actif, ou composition pour le soin des seins en periode pre-mensuelle ou menstruelle ou pour le soin de la symptomatologie des mastodynies
MA65548B1 (fr) *	2024-04-29	2026-03-31	Az-Pharma Laboratoires	Formulation dermatologique sans alcool pour l’acnes , l’herpes et les plaies superficielles

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2461744A1 (fr) *	1979-07-19	1981-02-06	Desjonqueres Stephane	Perfectionnement a la peroxydation de matieres grasses
FR2591109B1 (fr)	1985-12-06	1989-03-31	Desjonqueres Stephane	Composition medicamenteuse a base d'huile naturelle d'origine vegetale destinee a etre utilisee pour le traitement d'herpes.
JPH06698B2 (ja) *	1985-12-26	1994-01-05	積水化学工業株式会社	外用貼付剤
FR2731615B1 (fr) *	1995-03-15	1997-07-25	Fabre Pierre Dermo Cosmetique	Compositions ecran-solaire comprenant un melange de particules d'oxyde de titane et/ou de zinc, leur procede de preparation et leur utilisation
FR2744017B1 (fr) *	1996-01-26	1998-04-30	Carilene Lab	Associations de lipides peroxydes et de composes organosiliciques, compositions cosmetiques et dermatologiques les contenant et leurs applications notamment pour le traitement de l'alopecie
FR2797586B1 (fr) *	1999-08-16	2001-11-09	Stephane Desjonqueres	Utilisation de lipides peroxydes comme agents destines a former un film lipidique sur la peau
FR2824474B1 (fr) *	2001-05-11	2004-01-02	Fabre Pierre Dermo Cosmetique	Composition cosmetique a base de sucralfate et de sulfates de cuivre et de zinc
US6475526B1 (en) *	2001-06-05	2002-11-05	Jeffrey B. Smith	Zinc containing compositions for anti-viral use
DE10161729A1 (de) *	2001-12-15	2003-06-18	Mira Ursic	Medizinische bzw. pharmazeutische Salbenzubereitung
US6686392B1 (en) *	2002-10-01	2004-02-03	Elena Avram	Lipidic zinc compounds and use for treatment of prostatic hypertrophy
NL1022532C2 (nl) *	2003-01-30	2004-08-03	Pronovamedical B V	Samenstelling voor de preventieve behandeling van koortsuitslag.
CA2514381A1 (en) *	2005-07-29	2007-01-29	Collins T. Harvey	Improved topical preparation and method for using same to destroy herpes simplex cells
ITRM20070582A1 (it) *	2007-11-08	2009-05-09	Mauro Carratelli	Composizione farmaceutica comprendente olio e colesterolo perossidati e suoi usi in campo medico.

2009
- 2009-12-24 FR FR0959604A patent/FR2954701B1/fr active Active
2010
- 2010-12-17 US US12/971,055 patent/US9144612B2/en active Active
- 2010-12-20 PL PL10195981T patent/PL2343038T3/pl unknown
- 2010-12-20 BR BRPI1010325A patent/BRPI1010325B1/pt not_active IP Right Cessation
- 2010-12-20 DK DK10195981.5T patent/DK2343038T3/en active
- 2010-12-20 EP EP10195981.5A patent/EP2343038B1/fr active Active
- 2010-12-20 ES ES10195981T patent/ES2531407T3/es active Active
- 2010-12-20 PT PT101959815T patent/PT2343038E/pt unknown
- 2010-12-20 SI SI201030868T patent/SI2343038T1/sl unknown
- 2010-12-20 RS RS20150043A patent/RS53787B1/sr unknown
- 2010-12-22 AR ARP100104870A patent/AR080633A1/es not_active Application Discontinuation
2014
- 2014-12-29 CY CY20141101089T patent/CY1115914T1/el unknown
2015
- 2015-01-09 HR HRP20150027AT patent/HRP20150027T1/hr unknown

Also Published As

Publication number	Publication date
DK2343038T3 (en)	2015-01-26
FR2954701A1 (fr)	2011-07-01
ES2531407T3 (es)	2015-03-13
SI2343038T1 (sl)	2015-03-31
AR080633A1 (es)	2012-04-25
CY1115914T1 (el)	2017-01-25
BRPI1010325A2 (pt)	2014-02-25
HRP20150027T1 (hr)	2015-03-13
US20110159106A1 (en)	2011-06-30
FR2954701B1 (fr)	2012-02-03
RS53787B1 (sr)	2015-06-30
EP2343038B1 (fr)	2014-11-26
US9144612B2 (en)	2015-09-29
PT2343038E (pt)	2015-02-05
BRPI1010325B1 (pt)	2019-09-03
EP2343038A1 (fr)	2011-07-13

Publication	Publication Date	Title
IL248880B (en)	2021-03-25	Preparations containing r-g-cysteic acid peptides and their uses for the treatment of eye diseases
LT2365829T (lt)	2017-10-25	Oksidanto ir fotoaktyvatoriaus derinys, skirtas žaizdų gijimui
IL210673A (en)	2015-02-26	Fats, supplements and preparations containing them and their uses
GB201010897D0 (en)	2010-08-11	Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
PL2278952T3 (pl)	2020-07-27	Środki do czyszczenia skóry i rąk
ZA201101517B (en)	2011-10-26	Compositions for the prophylaxis and treatment of dermatological/mucosal diseases,and uses thereof
ZA201101424B (en)	2011-10-26	Aminophosphinic derivatives that can be used in the treatment of pain
IL212672A (en)	2016-10-31	Cycloandesdepsipeptide compounds and their use in drug production
PL2343038T3 (pl)	2015-04-30	Kompozycje dermatologiczne zawierające połączenie peroksydowanych lipidów i cynku oraz ich zastosowania, zwłaszcza w leczeniu opryszczki
IL216205A0 (en)	2012-01-31	Use of lipid conjugates in the treatment of diseases associated with vasculature
IL216717A0 (en)	2012-02-29	USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES
EP2421552B8 (en)	2017-01-25	Collagen v for use in the treatment of asthma
EP2363132A4 (en)	2013-02-13	USE OF SOPHORICOSIDE IN DRUG MANUFACTURE
PT2182954T (pt)	2019-02-06	Utilização de ácidos nor-biliares no tratamento de arteriosclerose
ZA201204014B (en)	2013-01-31	Use of secreted phospholipases a2 in the diagnosis and treatment of malaria
GB0821594D0 (en)	2008-12-31	Improvements in or relating to the treatment of tissue damage
IL191123A0 (en)	2009-02-11	Composition comprising phospholipids in combination with ascorbic acid and cosmetic products comprising it
GB2466110B (en)	2011-01-05	Antibacterial formulation for use in the treatment of acne
AP3019A (en)	2014-10-31	Use of ferroquine in the treatment or prevention of malaria
ZA201005770B (en)	2012-07-25	The treatment of damaged skin
GB2473735B (en)	2014-05-07	Skin treatment formulation
GB0911581D0 (en)	2009-08-12	Compositions for use in the treatment of dry eye
AU2009904943A0 (en)	2009-10-29	Skin Treatment Formulation
GB0819037D0 (en)	2008-11-26	Skin treatment formulation
AU2010904479A0 (en)	2010-10-28	The use of a novel compound GMGB1 in the treatment of depression and other non-infectious diseases